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Cuspor are the European agents and technical specialists for  
FreeThink Technologies Inc. products and services. 
 
FreeThink is a thought leader in the science and technology  
of stability studies, with some of the most knowledgeable and  
experienced research scientists in the field. 
 
FreeThink scientists have developed a broad fundamental understanding of how 
temperature, humidity, oxygen, light and time influence the shelf-life of products. As a 
result, we are adept at helping customers find appropriate, cost-effective solutions to 
their stability challenges, including physical changes of active 
forms, formulations, packaging and storage conditions. 
 
FreeThink is the scientific expert in stability, committed to developing phase-appropriate 
stability-indicating methods and applying them to your project.  We lead the industry in 
accelerated processes for modelling product shelf-life, obtaining results in just a few 
weeks using the ASAPprime® stability software we developed. Our team also excels at 
longer-term traditional studies, such as those based on the ICH guidelines, and cGMP 
studies that meet all criteria for regulatory filings. In our state-of-the-art labs, stability 
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Measurements of plasma protein binding – variety of experimental techniques 
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Drug molecules in vivo may be bound to proteins and lipids in plasma and/or in tissues, or 
free (unbound) in diffusion among the aqueous environment of the blood and tissues. 
Data from in vitro plasma protein binding experiments that determine the fraction of 
protein-bound drug are frequently used in drug discovery [1]. 
Human plasma proteins contain around 40 % albumin (HSA), 1-acid glycoprotein (AGP) in 
much lower concentration (1-3 %) and immunoglobulins [2]. Methods used for drug – 
plasma protein binding (PPB) studies are numerous and can be divided into two main 
groups: separation methods (enabling the calculation of binding parameters, i.e. the num-
ber of binding sites and their respective affinity constants) and non-separation methods 
(describing predominantly qualitative parameters of the ligand-protein complex) [3]. 
Sometimes, results of PPB measurements obtained by different techniques are not 
consistent. High binding affinity to plasma proteins is not necessarily a crucial limiting 
factor for further delivery of compound to the target organ [1]. As an example, we show 
the study of the interactions between HSA/AGP and an “in-house” synthesized steroidal 
derivative that showed remarkable inhibitory potency against BoNT/A holotoxin in mouse 
embryonic stem cell derived motor neurons [4]. A variety of experimental techniques (ITC, 
HPLC, spectrofluorimetry, FTIR, and equilibrium dialysis) were used and the results were 
compared highlighting the advantages and disadvatages of various techniques. 
 
Acknowledgement: Ministry of Education, Science and Technological Development of 
Serbia (Grant No. 172008) and Serbian Academy of Sciences and Arts supported this work. 
 
References: 
[1] D.A. Smith, L. Di, E.H. Kerns, Nat. Rev. Drug Discov. 9 (2010) 929-939. 
[2] K. Valko, Application of HPLC for the measurements of lipophilicity and bio-mimetic 
binding properties in drug discovery, in: Z. Mandić (Ed.), Physico-Chemical Methods in 
Drug Discovery and Development, IAPC Publishing, Zagreb, Croatia, 2012, pp. 61-119. 
[3] J. Oravcova, B. Bohs, W. Lindner, J. Chromatogr. B 677 (1996) 1-28. 
[4] J. Konstantinovic,́ E. Kiris, J. Kugelman-Tonos, M. Videnović, L. Cazares, N. Terzic,́ T.Ž. 
Verbic,́ M. Zlatovic,́ B. Andjelković, J. Srbljanović, A.J. Duplantier, S. Bavari, B.A. Šolaja, New 
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